Royalty Pharma (RPRX) PT Raised to $50 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Steve Scala raised the price target on Royalty Pharma (NASDAQ: RPRX) to $50.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
